| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.15B | 3.73B | 73.56B | 73.63B | 73.70B |
| Gross Profit | 1.37B | 1.33B | 8.48B | 11.31B | 13.50B |
| EBITDA | 900.23M | 925.81M | 4.62B | 7.04B | 8.90B |
| Net Income | 559.30M | -2.06B | 913.58M | 1.73B | 3.74B |
Balance Sheet | |||||
| Total Assets | 9.63B | 9.72B | 201.58B | 251.94B | 288.52B |
| Cash, Cash Equivalents and Short-Term Investments | 1.86B | 1.03B | 17.65B | 27.93B | 36.84B |
| Total Debt | 785.29M | 833.67M | 38.17B | 48.61B | 56.55B |
| Total Liabilities | 4.59B | 4.64B | 151.46B | 201.62B | 240.71B |
| Stockholders Equity | 4.91B | 4.90B | 25.31B | 24.86B | 23.51B |
Cash Flow | |||||
| Free Cash Flow | 947.09M | -2.37B | 3.43B | 2.84B | 3.05B |
| Operating Cash Flow | 975.69M | -2.26B | 3.63B | 3.04B | 3.21B |
| Investing Cash Flow | 199.83M | -14.25B | 4.65B | 5.38B | 3.44B |
| Financing Cash Flow | -603.01M | -6.04M | -12.58B | -12.95B | 1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$6.91B | 9.91 | 36.16% | 6.94% | 14.12% | 8.98% | |
75 Outperform | HK$16.91B | 10.46 | 15.06% | 4.43% | 4.91% | 4.61% | |
71 Outperform | HK$14.48B | 15.06 | 11.18% | 2.78% | 6.95% | 28.21% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | HK$4.45B | 9.44 | ― | 10.24% | ― | ― | |
59 Neutral | HK$3.61B | 27.68 | -12.90% | 4.41% | -7.01% | ― | |
57 Neutral | HK$20.07B | 30.19 | 1.68% | 4.94% | 9.98% | -68.38% |